SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 2141052

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 2141052

Blood Glucose Meters (BGM) Devices Market Size, Share, and Growth Analysis, By Meter Type, By Testing Method, By Connectivity, By Application, By End User, By Region - Industry Forecast 2026-2033

PUBLISHED:
PAGES: 157 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Blood Glucose Meters (Bgm) Devices Market size was valued at USD 5.2 Billion in 2024 and is poised to grow from USD 5.55 Billion in 2025 to USD 9.41 Billion by 2033, growing at a CAGR of 6.8% during the forecast period (2026-2033).

The global blood glucose meters (BGM) market is driven by the critical need for accurate blood sugar measurement, essential for effective diabetes management among millions of adults living with the condition. With an expected increase in diabetic patients, the demand for BGMs continues to grow. The market has rapidly transitioned from bulky laboratory devices to advanced, smartphone-compatible meters, demonstrated by products like Accu-Chek and FreeStyle Libre. Integrating health ecosystems fosters data sharing that enhances patient outcomes, compelling providers and payers to embrace these technologies. Additionally, AI integration is revolutionizing BGMs by improving measurement accuracy and user experience through predictive algorithms and intuitive interfaces, resulting in smarter, connected devices that alleviate patient anxiety while augmenting clinician insights for tailored care and fostering a shift toward subscription-based models.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Blood Glucose Meters (Bgm) Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Blood Glucose Meters (Bgm) Devices Market Segments Analysis

Global blood glucose meters (bgm) devices market is segmented by meter type, testing method, connectivity, application, end user and region. Based on meter type, the market is segmented into Standard Blood Glucose Meters, Smart Blood Glucose Meters and Continuous-Connected Glucose Meters. Based on testing method, the market is segmented into Strip-Based and Strip-Free. Based on connectivity, the market is segmented into Bluetooth, Wi-Fi and Cellular. Based on application, the market is segmented into Type 1 Diabetes and Type 2 Diabetes. Based on end user, the market is segmented into Hospitals & Clinics, Diagnostic Centers and Homecare. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Blood Glucose Meters (Bgm) Devices Market

The increasing prevalence of diabetes globally is fueling the demand for convenient self-monitoring devices, as patients actively seek real-time glucose information for effective management of their condition. Healthcare professionals advocate for regular testing to enhance glycemic control, promoting the use of portable glucose meters. This growing awareness of the advantages of effective disease management drives continuous advancements in device precision and user experience, further propelling market growth. Both consumers and healthcare providers emphasize the importance of dependable monitoring solutions. Moreover, regulatory support for patient-centered care reinforces this trend across various healthcare environments, contributing to ongoing market development.

Restraints in the Global Blood Glucose Meters (Bgm) Devices Market

The Global Blood Glucose Meters (BGM) Devices market faces challenges due to the relatively high prices of advanced models, especially those with continuous monitoring capabilities and integrated connectivity, which restrict broad consumer adoption. In many regions, reimbursement policies do not adequately support the cost of premium devices, leading patients to opt for basic glucose meters or alternative monitoring methods. This financial sensitivity discourages investment in newer technologies, despite their potential clinical advantages, resulting in slower market penetration. Thus, manufacturers are compelled to find a balance between innovation and affordability to effectively engage price-sensitive consumers and alleviate this barrier to growth.

Market Trends of the Global Blood Glucose Meters (Bgm) Devices Market

The Global Blood Glucose Meters (BGM) Devices market is witnessing a significant trend towards the creation of a connected-care ecosystem. This trend emphasizes the integration of blood glucose meters with smartphones and cloud platforms, facilitating real-time data sharing and remote patient monitoring. Such advancements allow clinicians to promptly adjust therapies and deliver personalized lifestyle recommendations. The incorporation of technologies like Bluetooth, NFC, and AI-driven analytics transforms raw glucose readings into valuable insights, enhancing patient compliance. Additionally, this integration opens new revenue avenues through subscription-based health services and data-driven partnerships, ultimately aiming to improve health outcomes and reduce hospitalizations on a global scale.

Product Code: SQMIG35A4486

Table of Contents

Introduction

  • Objectives of the Study
  • Market Definition & Scope

Research Methodology

  • Research Process
  • Secondary & Primary Data Methods
  • Market Size Estimation Methods

Executive Summary

  • Global Market Outlook
  • Key Market Highlights
  • Segmental Overview
  • Competition Overview

Market Dynamics & Outlook

  • Macro-Economic Indicators
  • Drivers & Opportunities
  • Restraints & Challenges
  • Supply Side Trends
  • Demand Side Trends
  • Porters Analysis & Impact
    • Competitive Rivalry
    • Threat of Substitute
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factors
  • Market Impacting Factors
  • Top Investment Pockets
  • Ecosystem Mapping
  • Market Attractiveness Index 2025
  • PESTEL Analysis
  • Regulatory Landscape

Global Blood Glucose Meters (BGM) Devices Market Size by Meter Type & CAGR (2026-2033)

  • Market Overview
  • Standard Blood Glucose Meters
  • Smart Blood Glucose Meters
  • Continuous-Connected Glucose Meters

Global Blood Glucose Meters (BGM) Devices Market Size by Testing Method & CAGR (2026-2033)

  • Market Overview
  • Strip-Based
  • Strip-Free

Global Blood Glucose Meters (BGM) Devices Market Size by Connectivity & CAGR (2026-2033)

  • Market Overview
  • Bluetooth
  • Wi-Fi
  • Cellular

Global Blood Glucose Meters (BGM) Devices Market Size by Application & CAGR (2026-2033)

  • Market Overview
  • Type 1 Diabetes
  • Type 2 Diabetes

Global Blood Glucose Meters (BGM) Devices Market Size by End User & CAGR (2026-2033)

  • Market Overview
  • Hospitals & Clinics
  • Diagnostic Centers
  • Homecare

Global Blood Glucose Meters (BGM) Devices Market Size & CAGR (2026-2033)

  • North America (Meter Type, Testing Method, Connectivity, Application, End User)
    • US
    • Canada
  • Europe (Meter Type, Testing Method, Connectivity, Application, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Meter Type, Testing Method, Connectivity, Application, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Meter Type, Testing Method, Connectivity, Application, End User)
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Meter Type, Testing Method, Connectivity, Application, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • F. Hoffmann-La Roche Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ascensia Diabetes Care
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LifeScan, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ARKRAY, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bayer AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AgaMatrix, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Trividia Health, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nipro Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • i-SENS, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sinocare Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ypsomed AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dexcom, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • A. Menarini Diagnostics S.r.l.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • TaiDoc Technology Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nova Biomedical
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • 77 Elektronika Kft.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun SE
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!